CG Oncology (CGON) Share-based Compensation (2023 - 2026)
CG Oncology (CGON) reported Share-based Compensation of $14.33 million for Q2 2026, up 104.6% from $7.01 million a year earlier and up 121.4% from the prior quarter.
Powered by 
Analysis
CG Oncology (CGON) Share-based Compensation (2023 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, CG Oncology's Share-based Compensation came in at $35.33 million, up 78.4% year-over-year; for FY2025, it was $26.68 million, up 134.0% from FY2024.
- By year, Share-based Compensation came in at $11.4 million in FY2024 (+646.2%) and $1.53 million in FY2023.
- The Q2 2026 figure ranks as the highest quarterly Share-based Compensation in data going back to Q1 2023.
- Year over year, Share-based Compensation has now increased in each of the last eight quarters, with growth averaging 239.5% over the last eight quarters.
- The year-over-year growth in Share-based Compensation has ranged between 25.7% (Q1 2026) and 747.5% (Q1 2024) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at $6.47 million (Q1 2026), $7.19 million (Q4 2025) and $7.33 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | CG Oncology | 6.15 Bn | 6.15 Bn | -2.77 Mn | 14.33 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14.33 Mn |
| Mar 31, 2026 | 6.47 Mn |
| Dec 31, 2025 | 7.19 Mn |
| Sep 30, 2025 | 7.33 Mn |
| Jun 30, 2025 | 7.01 Mn |
| Mar 31, 2025 | 5.15 Mn |
| Dec 31, 2024 | 4.99 Mn |
| Sep 30, 2024 | 2.65 Mn |
| Jun 30, 2024 | 2.25 Mn |
| Mar 31, 2024 | 1.52 Mn |
| Dec 31, 2023 | 778,000.00 |
| Sep 30, 2023 | 394,000.00 |
| Jun 30, 2023 | 177,000.00 |
| Mar 31, 2023 | 179,000.00 |
API Access
CG Oncology Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CGON&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "CGON", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=CGON&period=max&api_key=YOUR_API_KEY");
const data = await res.json();